Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies
Background: In patients with Multiple Sclerosis (pwMS) disease-modifying therapies (DMTs) affects immune response to antigens. Therefore, post-vaccination serological assessments are needed to evaluate the effect of the vaccine on SARS-CoV-2 antibody response. Methods: We designed a prospective mult...
Salvato in:
| Autori principali: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2021-10-01
|
| Serie: | EBioMedicine |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2352396421003741 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
